Mürşit DİNCER, Mustafa DUMAN, Ayşegül YEŞİLGÖZ SELEK, Orhan UZUN, Aziz Serkan SENGER

Sigmoid Kolonda Obstruksiyon ve Perforasyona Neden Olan Malign Mezotelyoma

Malign mezotelyoma peritoneal tutulumu nadir olan tanısı güç konulan bir hastalıktır. Çoğunlukla hastalarda karın ağrısı, asit, karın içi kitle ile bulgu verir. Tanı daha çok laparoskopi veya laparotomi sırasında konulur. Patolojik incelemede özel immünohistokimyasal boyalar tanıyı destekler. Cerrahi en etkili tedavi yöntemidir. Burada intraabdominal abse kliniği ile ortaya çıkan sigmoid kolonda obstruksiyon ve perforasyona yol açan malign mezotelyoma vakasını sunduk. Literatür gözden geçirildiğinde kolon perforasyonuna neden olan malign mezotelyoma olgusuna rastlanmadı.

Malign Mesothelioma Presenting with Features of Sigmoid Colon Obstruction and Perforation

Malign mesothelioma of the peritoneum is rareand its diagnosis is difficult. Most patients affectedby this tumor have abdominal pain, ascites andabdominal mass. Diagnosis is commonly made bylaparoscopy or laparotomy. Specialimmunohistochemical staining supports thediagnosis. Surgery is the most effective treatment.In this report, we describe a malignantmesothelioma presenting with features of colontumor perforation. Literature is reviewed, there isno case report with malignant mesotheliomapresenting with features of colon tumorperforation.

PDF

___

1. Khalil MW, Campbell AP, Cowen ME. Epithelioid malignant mesothelioma presenting with features of esophageal tumor. Asian Cardiovasc Thorac Ann 2011 Jun; 19: 260-261.
2. Gutzeita A, Reischauera C, Herganc K, Kosb S, Roosa JE. Secondary Malignant Peritoneal Mesothelioma of the Greater Omentum after Therapy for Primary Pleural Mesothelioma. Case Rep Oncol 2013; 6: 236–241.
Peritoneal Mesothelioma: A rare Case Report. Annals of Nuclear Medicine and Molecular İmaging 2011; 24: 138-140.
4. Feldman AL, Libutti SK, Pingpank JF, et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing Surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 2003; 21: 4560-4567.